Range Low Price High Price Comment
30 days $68.59 $84.57 Thursday, 28th Mar 2024 AXSM stock ended at $79.80. This is 0.796% more than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 3.76% from a day low at $77.08 to a day high of $79.98.
90 days $68.59 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
2023-11-02 $65.35 $66.20 $64.37 $64.40 533 444
2023-11-01 $61.99 $64.86 $61.48 $64.62 649 869
2023-10-31 $60.03 $62.29 $58.61 $62.28 468 864
2023-10-30 $62.55 $63.09 $59.70 $60.03 604 804
2023-10-27 $63.83 $63.83 $61.33 $62.08 594 266
2023-10-26 $63.84 $65.68 $63.71 $64.05 563 010
2023-10-25 $63.31 $64.98 $62.25 $63.88 577 045
2023-10-24 $63.24 $64.60 $62.62 $63.72 642 872
2023-10-23 $64.05 $64.05 $61.92 $62.01 523 731
2023-10-20 $64.50 $64.87 $63.80 $64.25 542 452
2023-10-19 $64.88 $65.76 $63.80 $64.25 551 449
2023-10-18 $65.74 $65.96 $64.65 $65.05 502 308
2023-10-17 $66.35 $67.95 $65.86 $66.01 379 513
2023-10-16 $66.45 $67.06 $64.09 $66.91 856 656
2023-10-13 $66.23 $67.43 $65.65 $66.47 559 221
2023-10-12 $70.29 $70.36 $66.15 $66.51 599 601
2023-10-11 $70.48 $71.21 $68.62 $70.19 424 576
2023-10-10 $70.39 $71.23 $69.82 $70.56 427 474
2023-10-09 $68.60 $70.40 $67.79 $70.38 464 925
2023-10-06 $66.35 $69.99 $66.26 $68.60 668 604
2023-10-05 $64.33 $67.53 $64.33 $67.36 582 163
2023-10-04 $63.41 $65.00 $63.26 $64.61 924 347
2023-10-03 $66.59 $66.80 $63.67 $63.83 815 018
2023-10-02 $70.00 $70.00 $66.64 $66.85 1 037 665
2023-09-29 $73.42 $74.49 $69.42 $69.89 723 448
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT